BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

NonExomics

NonExomics logo

Founded
2021
Geography
United States of America based
Funding
$0.200 M

NonExomics apply machine learning technology to discover drugs for diseases arising specifically from non-exom issues. The company integrates all kinds of omics data – genomics, transcriptomics, proteomics – to predict nonexomic proteins and identify disease-causing targets. NonExomics partners with other biopharma organizations to design biomarker assays, identify biomarker candidates, therapeutic targets and drugs.

Technologies

AI Companies (Drug Discovery)  

R&D Platform

-


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet